VIP and Drug Design
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
483-494
Author(s):
Illana Gozes and Sharon Furman
The Prodigiosins: A New Family of Anticancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
57-65
Author(s):
Beatriz Montaner and Ricardo Pérez-Tomás
subject Index To Volume 2
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
85-87
Author(s):
Bentham Science Publishers
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
21-37
Author(s):
C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres
Advances in Gene Therapy for Bladder Cancer
Journal:
Current Gene Therapy
Volume:
3
Page:
1-11
Author(s):
Akira Irie
Gene Therapy for Ischemic Brain Diseases
Journal:
Current Gene Therapy
Volume:
3
Page:
49-58
Author(s):
Youichi Saitoh, Amami Kato, Yasushi Hagihara, Yasufumi Kaneda and Toshiki Yoshimine
Subject Index To Volume 8
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
103-117
Author(s):
Bentham Science Publishers
Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
1-14
Author(s):
Stephan Ruetz, Doriano Fabbro, Juerg Zimmermann, Thomas Meyer and Nathanael Gray
Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Journal:
Current Drug Targets
Volume:
3
Page:
465-482
Author(s):
J.E. Trosko and R.J. Ruch
Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
337-353
Author(s):
B. G. Gabrielli, R. W. Johnstone and N. A. Saunders